199 related articles for article (PubMed ID: 4640955)
1. The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
Spitler LE; Levin AS; Stites DP; Fudenberg HH; Pirofsky B; August CS; Stiehm ER; Hitzig WH; Gatti RA
J Clin Invest; 1972 Dec; 51(12):3216-24. PubMed ID: 4640955
[TBL] [Abstract][Full Text] [Related]
2. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
[TBL] [Abstract][Full Text] [Related]
3. Restoration of cell-mediated immune responses with transfer factor.
Kirkpatrick CH
Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
[TBL] [Abstract][Full Text] [Related]
4. Effect of transfer factor on lymphocyte function in anergic patients.
Kirkpatrick CH; Rich RR; Smith TK
J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
Altman LC; Snyderman R; Blaese RM
J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
[TBL] [Abstract][Full Text] [Related]
6. Transfer factor I: methods of therapy.
Levin AS; Spitler LE; Fudenberg HH
Birth Defects Orig Artic Ser; 1975; 11(1):445-8. PubMed ID: 1080060
[TBL] [Abstract][Full Text] [Related]
7. Use of transfer factor in patients with depressed cellular immunity and chronic infection.
Rocklin RE
Birth Defects Orig Artic Ser; 1975; 11(1):431-5. PubMed ID: 1096987
[TBL] [Abstract][Full Text] [Related]
8. Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor.
Levin AS; Spitler LE; Stites DP; Fudenberg HH
Proc Natl Acad Sci U S A; 1970 Oct; 67(2):821-8. PubMed ID: 5289024
[TBL] [Abstract][Full Text] [Related]
9. Transfer factor therapy in immuno-deficiencies.
Griscelli C; Revillard JP; Betuel H; Herzog C; Touraine JL
Biomedicine; 1973 May; 18(3):220-7. PubMed ID: 4742861
[No Abstract] [Full Text] [Related]
10. Update of the Wiskott-Aldrich syndrome. From a new case report.
Martín Mateos MA; Muñoz-López F; Cruz M
Allergol Immunopathol (Madr); 1988; 16(2):113-9. PubMed ID: 3394592
[TBL] [Abstract][Full Text] [Related]
11. Transfer factor II: results of therapy.
Spitler LE; Levin AS; Fudenberg HH
Birth Defects Orig Artic Ser; 1975; 11(1):449-56. PubMed ID: 1096990
[TBL] [Abstract][Full Text] [Related]
12. Transfer factor therapy in immunodeficiency.
Griscelli C
Birth Defects Orig Artic Ser; 1975; 11(1):462-4. PubMed ID: 1148388
[No Abstract] [Full Text] [Related]
13. Transfer factor therapy: evidence for nonspecificity.
Ballow M; Dupont B; Hansen JA; Good RA
Birth Defects Orig Artic Ser; 1975; 11(1):457-61. PubMed ID: 125119
[TBL] [Abstract][Full Text] [Related]
14. [Discrepancy between the clinical and immunologic picture of in vitro diagnosis during transfer factor therapy in a patient with Wiscott-Aldrich syndrome].
Schütt C; Eggers G; Schröder I; Kruse H; Schulz M; Blau HJ
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):677-84. PubMed ID: 6198251
[TBL] [Abstract][Full Text] [Related]
15. Nephropathy in the Wiskott-Aldrich syndrome.
Spitler LE; Wray BB; Mogerman S; Miller JJ; O'Reilly RJ; Lagios M
Pediatrics; 1980 Sep; 66(3):391-8. PubMed ID: 7422429
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of the transfer factor].
Mutz I; Humphrey GB
Wien Klin Wochenschr; 1973 May; 85(20):357-60. PubMed ID: 4574399
[No Abstract] [Full Text] [Related]
17. Abnormal immune responses in the ocular presentation of Wiskott-Aldrich syndrome.
Guss RB; McCulley JP
Ann Ophthalmol; 1982 Nov; 14(11):1058-60. PubMed ID: 7181336
[TBL] [Abstract][Full Text] [Related]
18. Wiskott Aldrich syndrome: a treatable immune disorder. A review.
Millikan LE
Mo Med; 1973 Nov; 70(11):764-7 passim. PubMed ID: 4591682
[No Abstract] [Full Text] [Related]
19. [Transfer factor. Immunologic basis and therapeutic experience].
Hitzig WH; Fontanellaz HP; Müntener U; Paul S; Spitler LE; Fudenberg HH
Schweiz Med Wochenschr; 1972 Sep; 102(35):1237-44. PubMed ID: 5054632
[No Abstract] [Full Text] [Related]
20. [Transfer factor and its therapeutic use].
Rosenthal M
Schweiz Med Wochenschr; 1974 Oct; 104(43):1501-6. PubMed ID: 4549135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
